We believe in communicating and working toward solutions with the patient, pharmacist, and provider because our patients deserve attention to every detail.
Our state of the art lab and skilled technicians bring our products to a whole new level of quality. Each and every order is made with extreme attention to detail.
Low-Dose Naltrexone requires a prescription from a provider. Haven't found a doctor to prescribe it for you? No worries, we can help you find one!
FREE WEBINARS | CONSULTATIONS | RESOURCE LIST
Your prescription is only part of the solution. We believe that knowledge and information is equally important for success with treatment. That's why we not only offer a long list of resources, but also frequent free webinars and one-on-one consultations with one of our pharmacists.
We typically have a free informational webinar every other month where we cover the basics of LDN, share testimonials, and give you a chance to ask questions. Register today for our next patient webinar.
Some times you need more direction, clarification, or have more specific questions. That's where our pharmacist consultations can be a useful tool. If you'd like to talk to one of our pharmacists about Low-Dose Naltrexone, please fill out the form below and we will reach out to set up a time to talk more.
FREE WEBINARS VIA ZOOM
Think that you or someone you know may benefit from Low-Dose Naltrexone? Curious about what LDN is? Want to hear about some of the research on LDN? Want to hear from others who may already be taking LDN and have had success? Our free webinars are a perfect answer to all of this!
Webinars are not only free, but you can attend from the comfort of your own home. Our webinars, through Zoom, are usually every other month and last for about an hour. We typically have time at the end to answer any questions.
Don't miss out on this one-of-a-kind opportunity to learn from leading pharmacists for free!
RESEARCH | WEBSITES | ARTICLES
LDN Research Trust
The LDN Research Trust works to educate patients and providers, support research, provide research and much more. The primary aim is to initiate clinical trials of Low-Dose Naltrexone for autoimmune diseases and cancers.
More Coming Soon...
The LDN Book
FIRST AND SECOND EDITIONS OF THE LDN BOOK
About the Author
Linda Elsegood is the founder of the LDN Research Trust, which was set up in the UK as a Registered Charity in 2004, and is the editor of The LDN Book.
Diagnosed with MS in August of 2000, she started LDN therapy in December of 2003, and now has a better quality of life and hope for the future.